Morgan Stanley Neuro Sense Therapeutics Ltd. Transaction History

Morgan Stanley

  • $1.59 Trillion
  • Q3 2025

A detailed history of Morgan Stanley transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Morgan Stanley holds 66,400 shares of NRSN stock, worth $65,072. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,400
Previous 79,900 16.9%
Holding current value
$65,072
Previous $151,000 45.03%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$1.04 - $2.11 $14,040 - $28,485
-13,500 Reduced 16.9%
66,400 $83,000
Q2 2025

Aug 15, 2025
BUY
$0.91 - $2.49 $26,753 - $73,203
29,399 Added 58.21%
79,900 $151,000
Q1 2025

May 15, 2025
SELL
$0.93 - $1.21 $48,434 - $63,016
-52,080 Reduced 50.77%
50,501 $46,000
Q4 2024

Feb 14, 2025
BUY
$0.86 - $1.36 $88,219 - $139,510
102,581 New
102,581 $123,000
Q2 2024

May 14, 2025
SELL
$0.84 - $2.06 $84,908 - $208,226
-101,081 Reduced 98.54%
1,500 $1,000
Q4 2023

Feb 13, 2024
BUY
$0.44 - $1.49 $660 - $2,235
1,500 New
1,500 $1,000
Q3 2022

Nov 14, 2022
BUY
$1.6 - $3.3 $6 - $13
4 New
4 $0

Others Institutions Holding NRSN

# of Institutions
11
Shares Held
278K
Call Options Held
0
Put Options Held
0
View Full List

About NeuroSense Therapeutics Ltd.

NRSN Quotes by TradingView
  • Ticker NRSN
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,674,000
  • Market Cap $11.4M
More about NRSN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email